debate: are novel targets such as her2 ready for prime time in colorectal cancer? - no
Published 7 years ago • 138 plays • Length 15:52Download video MP4
Download video MP3
Similar videos
-
22:10
novel agents and targets in colorectal cancer
-
13:18
debate 1: first-line treatment of metastatic colorectal cancer - calgb 80405
-
23:09
colorectal cancer: updates on novel agents and targets
-
7:37
debate: msi high colon cancer - upfront chemotherapy
-
11:54
debate: targeted therapy for ras/braf wt left sided colon cancers - bevacizumab or egfr antibodies
-
15:45
debate: optimal sequencing of multimodality treatment in rectal cancer - medical oncologist's pov
-
14:02
debate: complete response in rectal cancer? - surgery
-
0:07
signs and symptoms of colorectal cancer
-
7:20
debate: optimal salvage therapy for refractory colon cancer? - immunotherapy
-
27:23
key insights in colorectal cancer
-
0:56
how to prevent colon cancer (the short version)
-
16:38
the her-2 pathway in gi cancer
-
13:41
debate: complete response in rectal cancer? - watchful waiting
-
13:17
key insights: updates in colorectal cancer
-
26:20
colorectal cancer: the link between the immune microenvironment and outcomes
-
9:12
debate: is there an optimal treatment for refractory colorectal cancer? - immunotherapy
-
32:18
multidisciplinary tumor board: a challenging patient with colorectal cancer
-
0:41
how can immunotherapies successfully target mss colorectal cancer?